Peripheral Neuropathy in p.Val142Ile (Val122Ile) Variant Hereditary Transthyretin-Mediated Amyloidosis
Real-world experience from the UK national cohort of p.V142I ATTRv indicates that peripheral neuropathy is of a mild severity and less frequent than previously reported.
Authors
- Alexander Martin Rossor (ORCID: https://orcid.org/0000-0003-4648-2896)
- Dorota M. Rowczenio (ORCID: https://orcid.org/0000-0002-3511-6789)
- Mary M. Reilly (ORCID: https://orcid.org/0000-0003-0686-905X)
- Victor Jia Wei Zhang (ORCID: https://orcid.org/0000-0001-5951-4151)
- Mariola Skorupinska
- Janet A. Gilbertson (ORCID: https://orcid.org/0009-0007-8733-356X)
- Marianna Fontana (ORCID: https://orcid.org/0000-0002-9233-9831)
- Julian D. Gillmore (ORCID: https://orcid.org/0000-0001-6174-9232)
- Roy Carganillo (ORCID: https://orcid.org/0000-0003-1329-7563)
- Luke O’Donnell (ORCID: https://orcid.org/0000-0001-9514-1516)
Institutions
- The Royal Free Hospital (GB)
- National Hospital for Neurology and Neurosurgery (GB)
- University College London (GB)
Publication Details
- Journal
- Neurology Genetics
- Published
- 2025-09-24
- DOI
- https://doi.org/10.1212/nxg.0000000000200304
- Primary Topic
- Amyloidosis: Diagnosis, Treatment, Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00